Company News
Cohance Lifesciences Invests $18M in NJ Bio and Aruka Bio
Cohance Lifesciences' IBA Committee approved $18M in strategic ADC investments to increase stake in subsidiary NJ Bio from 56% to 67.3% and acquire 65% control of Aruka Bio.
The $13M NJ Bio transactio
